FEMASYS director granted 880 stock options

FEMASYS INC director Edward R. Uzialko received a grant of 880 stock options on 2026-06-24.

Rhea-AI Filing Summary

FEMASYS INC director Edward R. Uzialko received a grant of 880 stock options on 2026-06-24. Each option has an exercise price of $3.67 and is exercisable for one share of common stock, covering a total of 8,800 underlying shares. The options were granted at no purchase cost and will vest one year from the grant date, assuming continued service, and are scheduled to expire on 2036-06-24. Following this grant, Uzialko holds 880 derivative securities of this type directly.

Insider Trade Summary

Grant/Award: 880 shares

Grant/Award 1 txn

Insider Uzialko Edward R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	880	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 880 contracts (Direct)

Footnotes (1)

1. F1. The shares underlying the stock option vest one year from the date of grant, assuming continued service.

Key Figures

Options granted: 880 options Underlying shares: 8,800 shares Exercise price: $3.67 per share +4 more

7 metrics

Options granted 880 options Stock Option (Right to Buy) granted to director on 2026-06-24

Underlying shares 8,800 shares Common stock underlying the 880 stock options

Exercise price $3.67 per share Conversion or exercise price of the stock options

Grant date 2026-06-24 Date of stock option grant to director

Expiration date 2036-06-24 Scheduled expiration of the stock options

Price paid for options $0.00 per option Transaction price per option at grant

Post-transaction derivative holdings 880 options Total derivative securities of this type held directly after grant

Key Terms

Stock Option (Right to Buy), underlying security, exercise price, vesting

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

underlying security financial

"underlying_security_shares: 8800.0000 underlying security shares"

exercise price financial

"conversion_or_exercise_price: 3.6700 as the exercise price per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"shares underlying the stock option vest one year from the date of grant"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did FEMASYS INC (FEMY) director Edward R. Uzialko receive in this Form 4 filing?

Edward R. Uzialko received a grant of 880 stock options for FEMASYS INC common stock. These derivative securities give him the right to buy up to 8,800 shares subject to vesting and exercise terms.

What is the exercise price and cost of the new FEMASYS (FEMY) options?

The granted options have an exercise price of $3.67 per share and were issued at $0.00 per option. This means Uzialko pays nothing for the grant itself but must pay $3.67 per share to exercise.

When do Edward R. Uzialko’s FEMASYS (FEMY) options vest and expire?

The options vest one year from the 2026-06-24 grant date, assuming continued service. They are scheduled to expire on 2036-06-24 if not exercised before that date, according to the filing footnote.

How many FEMASYS (FEMY) shares are covered by the new stock option grant?

The grant covers 8,800 shares of common stock as the underlying security. Each of the 880 options is exercisable for one share, giving potential future ownership of 8,800 shares upon full vesting and exercise.

How many FEMASYS (FEMY) derivative securities does Uzialko hold after this transaction?

After this grant, Uzialko directly holds 880 stock options of this type. These options represent rights to acquire 8,800 shares of FEMASYS INC common stock, subject to vesting and exercise conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/11/2026 - 09:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Uzialko Edward R

(Last) (First) (Middle)

C/O FEMASYS INC.

3950 JOHNS CREEK COURT, SUITE 100

(Street)

SUWANEE GEORGIA 30024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FEMASYS INC [ FEMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$3.67	06/24/2026		A		880		(1)	06/24/2036	Common Stock	8,800	$0	880	D

Explanation of Responses:

1. The shares underlying the stock option vest one year from the date of grant, assuming continued service.

	/s/ Kathy Lee-Sepsick, Attorney-in-fact	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)